Zhitong Finance App News, True Health Medical-B (02697) issued an announcement. On August 22, 2026, the company and General Technology Liaoning Pharmaceutical Co., Ltd. signed a strategic cooperation framework agreement in Shenyang. Based in the three northeastern provinces, the two sides cooperate on the construction of minimally invasive cancer diagnosis and treatment systems, equipment compliance, and specialist capacity improvement, and adopt models such as joint specialist construction, equipment technical services, and operational leasing to promote standardized implementation of minimally invasive cancer intervention technology. The project strictly complies with relevant regulations, and reports from the Health Commission and the health insurance department will be completed before implementation.
General Technology Liaoning Pharmaceutical is the only provincial platform company established by “China Pharmaceutical and Health Industry Co., Ltd.” under “China General Technology (Group) Holdings Co., Ltd.”, an important state-owned enterprise directly managed by the central government. This cooperation will accelerate the large-scale implementation of the company's self-developed minimally invasive oncology surgery robots and specialist solutions in Northeast China, create a replicable oncology specialist model, and enable regional medical upgrading.
The board of directors believes that this cooperation has the complementary advantages of both parties, is conducive to enhancing the company's market influence, and conforms to the interests of the company and all shareholders.